Subscribe To
Biohaven drug is a long shot, but success could boost shares
Biohaven pharmaceutical Holding Company Ltd. ( BHVN , Financial) and its shareholders could be in for a...
March 22, 2022, 10:17 am
Terns reports topline results from early-stage nash study
Terns pharmaceuticals Inc (NASDAQ: TERN) reported topline results from Part 1 of Phase 1b AVIATION T...
March 22, 2022, 9:33 am
Why oric pharmaceuticals shares are plunging today
ORIC pharmaceuticals Inc (NASDAQ: ORIC) has decided to discontinue the further development of ORIC-10...
March 22, 2022, 9:33 am
Synaptogenix to present at sachs 5th annual neuroscience innovation forum
NEW YORK , March 22, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging bio...
March 22, 2022, 9:15 am
Infinity pharmaceuticals announces the date of its fourth quarter and full year 2021 financial results conference call and webcast
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biot...
March 22, 2022, 7:35 am
Novabay pharmaceuticals to hold 2021 fourth quarter and full year conference call on march 29
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® pharmaceuticals, Inc. (NYSE American: NBY) announces tha...
March 22, 2022, 6:50 am
Sage therapeutics to present at 2022 stifel cns days
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company ...
March 22, 2022, 6:30 am
Oric pharmaceuticals, inc.'s (oric) ceo jacob chacko on q4 2021 results - earnings call transcript
ORIC pharmaceuticals, Inc.'s (ORIC) CEO Jacob Chacko on Q4 2021 Results - Earnings Call Transcript...
March 21, 2022, 8:48 pm
Rigel pharmaceuticals: why the stock is on a run
RIGL announced Q4'21 earnings in early March leading the stock to rally over 20%....
March 21, 2022, 5:35 pm
Marinus pharmaceuticals, inc. (mrns) ceo dr. scott braunstein on q4 2021 results - earnings call transcript
Marinus pharmaceuticals, Inc. (MRNS) CEO Dr. Scott Braunstein on Q4 2021 Results - Earnings Call Transc...
March 21, 2022, 1:43 pm
Atai life sciences to participate in upcoming march investor conferences
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage bio...
March 21, 2022, 1:08 pm
Tonix says fibromyalgia candidate failed to achieve statistical significance over placebo
Tonix pharmaceuticals Holding Corp (NASDAQ: TNXP) says that as expected, TNX-102 SL (cyclobenzaprine H...
March 21, 2022, 10:20 am
2 top biotech stocks to buy right now
The global pharmaceutical industry grows in importance with each passing year. These two companies are ...
March 21, 2022, 10:00 am
Why are allena pharma shares plunging today
An independent data safety monitoring board (DSMB) has conducted the first of two planned Sample Size Reestimations (SSR1) of Phase 3 URIROX-2 Trial�...
March 21, 2022, 9:48 am
Avadel pharmaceuticals plc: initiating buy, bye bye to sleepiness
We are initiating AVDL at a speculative buy rating, with a target price of USD 14....
March 21, 2022, 9:46 am
Painreform to present at the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest on march 28th - 30th
TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty ...
March 21, 2022, 9:25 am
Wellbeing digital sciences says its kgk science subsidiary engaged by lophos pharmaceuticals for novel peyote study
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc announced that its wholly-owned subsidiary, KGK Science Inc has been engaged by Lophos
March 21, 2022, 8:26 am
Ionis to present at upcoming investor conferences
CARLSBAD, Calif. , March 21, 2022 /PRNewswire/ -- Ionis pharmaceuticals, Inc. (Nasdaq: IONS) today anno...
March 21, 2022, 7:05 am
Pardes biosciences to present at the international conference on antiviral research 2022
CARLSBAD, Calif. , March 21, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage bio...
March 21, 2022, 7:00 am
Shield therapeutics partner submits iron deficiency drug for approval in canada
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) said partner KYE pharmaceuticals Inc has made a new drug...
March 21, 2022, 3:22 am